BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

542 related articles for article (PubMed ID: 28641631)

  • 1. [Characteristics and Prognostic Significance of Cytogenetic Abnormalities in Diffuse Large B-Cell Lymphoma Patients with Bone Marrow Involvement].
    Liu W; Lyu R; Huang WY; Li CW; Liu H; Li J; Zou DH; Qiu LG; Yi SH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Jun; 25(3):761-765. PubMed ID: 28641631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of cytogenetic aberrations in bone marrow of patients with diffuse large B-cell lymphoma: prognostic significance and relevance to histologic involvement.
    Kim S; Kim H; Kang H; Kim J; Eom H; Kim T; Yoon SS; Suh C; Lee D;
    J Hematol Oncol; 2013 Oct; 6():76. PubMed ID: 24220305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poor prognosis in patients with diffuse large B cell lymphomas with bone marrow involvement possessing chromosomal abnormalities, despite aggressive treatment.
    Min GJ; Jeon YW; Park SS; Shin SH; Yahng SA; Yoon JH; Lee SE; Cho BS; Eom KS; Kim YJ; Lee S; Kim HJ; Min CK; Kim DW; Lee JW; Cho SG
    Ann Hematol; 2020 Mar; 99(3):557-570. PubMed ID: 31989249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathological analysis of polyploid diffuse large B-cell lymphoma.
    Shimono J; Miyoshi H; Kiyasu J; Kamimura T; Eto T; Miyagishima T; Nagafuji K; Seto M; Teshima T; Ohshima K
    PLoS One; 2018; 13(4):e0194525. PubMed ID: 29641580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Correlation of chromosomal aberrations with prognostic markers in multiple myeloma patients--a single institution study].
    Lee JW; Lee JK; Hong YJ; Hong SI; Chang YH
    Korean J Lab Med; 2008 Dec; 28(6):413-8. PubMed ID: 19127104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In B-cell chronic lymphocytic leukaemia chromosome 17 abnormalities and not trisomy 12 are the single most important cytogenetic abnormalities for the prognosis: a cytogenetic and immunophenotypic study of 480 unselected newly diagnosed patients.
    Geisler CH; Philip P; Christensen BE; Hou-Jensen K; Pedersen NT; Jensen OM; Thorling K; Andersen E; Birgens HS; Drivsholm A; Ellegaard J; Larsen JK; Plesner T; Brown P; Andersen PK; Hansen MM
    Leuk Res; 1997; 21(11-12):1011-23. PubMed ID: 9444933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromosome abnormalities in diffuse large B-cell lymphomas: analysis of 231 Chinese patients.
    Zhao X; Fan R; Lin G; Wang X
    Hematol Oncol; 2013 Sep; 31(3):127-35. PubMed ID: 23135954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of cytogenetic abnormalities in T-cell prolymphocytic leukemia.
    Hu Z; Medeiros LJ; Fang L; Sun Y; Tang Z; Tang G; Sun T; Quesada AE; Hu S; Wang SA; Pei L; Lu X
    Am J Hematol; 2017 May; 92(5):441-447. PubMed ID: 28194886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of bone marrow infiltration detected by PET-CT in newly diagnosed diffuse large B cell lymphoma.
    Liang JH; Sun J; Wang L; Fan L; Chen YY; Qu XY; Li TN; Li JY; Xu W
    Oncotarget; 2016 Apr; 7(14):19072-80. PubMed ID: 26919239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytogenetic aberrations and their prognostic value in a series of 330 splenic marginal zone B-cell lymphomas: a multicenter study of the Splenic B-Cell Lymphoma Group.
    Salido M; Baró C; Oscier D; Stamatopoulos K; Dierlamm J; Matutes E; Traverse-Glehen A; Berger F; Felman P; Thieblemont C; Gesk S; Athanasiadou A; Davis Z; Gardiner A; Milla F; Ferrer A; Mollejo M; Calasanz MJ; Florensa L; Espinet B; Luño E; Wlodarska I; Verhoef G; García-Granero M; Salar A; Papadaki T; Serrano S; Piris MA; Solé F
    Blood; 2010 Sep; 116(9):1479-88. PubMed ID: 20479288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical and cytogenetic study of chromosome 1 abnormality in myelodysplastic syndrome].
    Wang W; Chen Z; Yu M; Wang H; Lou J; Xu H; Hu C; Mu Q; Tong H; Wei J; Zhou X; Jin J
    Zhonghua Xue Ye Xue Za Zhi; 2015 Oct; 36(10):818-23. PubMed ID: 26477758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Analysis of survival and prognosis in 409 newly diagnosed patients with diffuse large B-cell lymphoma].
    Wen J; Zhou J; Liu Z; Liu T; Xu C
    Zhonghua Xue Ye Xue Za Zhi; 2014 Apr; 35(4):318-24. PubMed ID: 24759020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of concordant and discordant bone marrow involvement on outcome in diffuse large B-cell lymphoma treated with R-CHOP.
    Sehn LH; Scott DW; Chhanabhai M; Berry B; Ruskova A; Berkahn L; Connors JM; Gascoyne RD
    J Clin Oncol; 2011 Apr; 29(11):1452-7. PubMed ID: 21383296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-Hodgkin lymphoma with t(14;18): clonal evolution patterns and cytogenetic-pathologic-clinical correlations.
    Aamot HV; Torlakovic EE; Eide MB; Holte H; Heim S
    J Cancer Res Clin Oncol; 2007 Jul; 133(7):455-70. PubMed ID: 17235551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [THE PROGNOSTIC IMPACT OF CHROMOSOMAL ABERRATIONS IN TUMOR TISSUE BIOPSIES FROM PATIENTS WITH DIFFUSE LARGE B CELL LYMPHOMA].
    Fahoum I; Ziv M; Bar-El H; Attias D; Tadmor T
    Harefuah; 2016 Jan; 155(1):45-9, 66. PubMed ID: 27012075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The molecular cytogenetic aberration analyzed by comparative genomic hybridization and its significance in diffuse large B-cell lymphoma.
    Xia HL; Chen LJ; Chen B; Jin XL; Chen SJ
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Feb; 23(1):12-5. PubMed ID: 16456777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Karyotyping of diffuse large B-cell lymphomas: loss of 17p is associated with poor patient outcome.
    Fiskvik I; Aamot HV; Delabie J; Smeland EB; Stokke T; Heim S; Holte H
    Eur J Haematol; 2013 Oct; 91(4):332-8. PubMed ID: 23859481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytogenetic features of de novo CD5-positive diffuse large B-cell lymphoma: chromosome aberrations affecting 8p21 and 11q13 constitute major subgroups with different overall survival.
    Yoshioka T; Miura I; Kume M; Takahashi N; Okamoto M; Ichinohasama R; Yoshino T; Yamaguchi M; Hirokawa M; Sawada K; Nakamura S
    Genes Chromosomes Cancer; 2005 Feb; 42(2):149-57. PubMed ID: 15543600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High total metabolic tumor volume in PET/CT predicts worse prognosis in diffuse large B cell lymphoma patients with bone marrow involvement in rituximab era.
    Song MK; Yang DH; Lee GW; Lim SN; Shin S; Pak KJ; Kwon SY; Shim HK; Choi BH; Kim IS; Shin DH; Kim SG; Oh SY
    Leuk Res; 2016 Mar; 42():1-6. PubMed ID: 26851438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cytogenetic and clinical study on 126 cases of B cell non-Hodgkin's lymphoma with bone marrow involvement].
    An G; Zhang JW; Shi LH; Yi SH; Zhao YZ; Qi JY; Zou DH; Qiu LG
    Zhonghua Xue Ye Xue Za Zhi; 2011 Jan; 32(1):34-7. PubMed ID: 21429399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.